ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,879.62
      -0.30%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. CSE
      6. PharmaTher Holdings Ltd (PHRM)

      7. PharmaTher Holdings Ltd (PHRM) News

      PHRM

      PharmaTher (PHRM)

      PharmaTher Holdings Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:CSE:PHRM
      DateTimeSourceHeadlineSymbolCompany
      11/11/202110:00AMInvestorsHub NewsWirePharmaTher Announces Positive Research Results for Psilocybin Microneedle PatchCSE:PHRMPharmaTher Holdings Ltd
      11/03/20218:03AMInvestorsHub NewsWirePharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle PatchCSE:PHRMPharmaTher Holdings Ltd
      10/19/20217:07AMInvestorsHub NewsWirePharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine ProductsCSE:PHRMPharmaTher Holdings Ltd
      10/13/20219:20AMInvestorsHub NewsWirePharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain SyndromeCSE:PHRMPharmaTher Holdings Ltd
      09/21/202110:19AMInvestorsHub NewsWirePharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded FundCSE:PHRMPharmaTher Holdings Ltd
      09/13/20219:03AMInvestorsHub NewsWirePharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022CSE:PHRMPharmaTher Holdings Ltd
      08/04/20218:15AMInvestorsHub NewsWirePharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral SclerosisCSE:PHRMPharmaTher Holdings Ltd
      07/21/20218:19AMInvestorsHub NewsWirePharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine FormulationCSE:PHRMPharmaTher Holdings Ltd
      06/16/202111:14AMInvestorsHub NewsWirePharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat DepressionCSE:PHRMPharmaTher Holdings Ltd
      05/25/20218:45AMInvestorsHub NewsWirePharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's DiseaseCSE:PHRMPharmaTher Holdings Ltd
      05/17/20218:02AMInvestorsHub NewsWirePharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson's DiseaseCSE:PHRMPharmaTher Holdings Ltd
      04/27/20217:47AMInvestorsHub NewsWirePharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics..ContCSE:PHRMPharmaTher Holdings Ltd
      04/20/20218:00AMInvestorsHub NewsWirePharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical TrialCSE:PHRMPharmaTher Holdings Ltd
      04/15/202111:32AMInvestorsHub NewsWirePharmaTher Provides Update on Psychedelic Product ProgramsCSE:PHRMPharmaTher Holdings Ltd
      03/02/20217:34AMInvestorsHub NewsWirePharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou....ContCSE:PHRMPharmaTher Holdings Ltd
      02/17/202110:11AMInvestorsHub NewsWirePharmaTher Announces Sale of Psilocybin ProgramCSE:PHRMPharmaTher Holdings Ltd
      02/04/20218:21AMInvestorsHub NewsWirePharmaTher Announces Successful Completion of Pre-IND Meeting with FDACSE:PHRMPharmaTher Holdings Ltd
      02/01/20218:19AMInvestorsHub NewsWirePharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver KetamineCSE:PHRMPharmaTher Holdings Ltd
      01/19/20218:07AMInvestorsHub NewsWirePharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine FormulationCSE:PHRMPharmaTher Holdings Ltd
       Showing the most relevant articles for your search:CSE:PHRM